PMID

Data

Article Title

Organization

Rodent selectivity of piperidine-4-yl-1H-indoles, a series of CC chemokine receptor-3 (CCR3) antagonists: insights from a receptor model.

Boehringer Ingelheim Pharma

From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part I: the discovery of CCR3 antagonist development candidate BMS-639623 with picomolar inhibition potency against eosinophil chemotaxis.

Bristol-Myers Squibb

Synthesis, biological evaluation, and metabolic stability of acrylamide derivatives as novel CCR3 antagonists.

Astellas Pharma

CC chemokine receptor-3 (CCR3) antagonists: improving the selectivity of DPC168 by reducing central ring lipophilicity.

Bristol-Myers Squibb Pharmaceutical Research Institute

Discovery of CC chemokine receptor-3 (CCR3) antagonists with picomolar potency.

Pharmaceutical Research Institute

The synthesis of substituted bipiperidine amide compounds as CCR3 antagonists.

Schering-Plough Research Institute

Design, synthesis, and discovery of a novel CCR1 antagonist.

Banyu Tsukuba Research Institute In Collaboration With Merck Research Laboratories